PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 7 |
| 2000 | 34 |
| 2001 | 28 |
| 2002 | 34 |
| 2003 | 38 |
| 2004 | 55 |
| 2005 | 81 |
| 2006 | 87 |
| 2007 | 101 |
| 2008 | 77 |
| 2009 | 90 |
| 2010 | 116 |
| 2011 | 80 |
| 2012 | 25 |
| 2013 | 18 |
| 2014 | 18 |
| 2015 | 30 |
| 2016 | 30 |
| 2017 | 28 |
| 2018 | 25 |
| 2019 | 34 |
| 2020 | 47 |
| 2021 | 53 |
| 2022 | 38 |
| 2023 | 23 |
| 2024 | 32 |
| 2025 | 39 |
| 2026 | 11 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Mol Diagn"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Yield of an Active Candida auris Molecular Surveillance Program at a Tertiary Care Cancer Center.
- Jani K, McMillen T, Lee C, Miranda E, Rizzo S, Aslam A, Bubb T, Kamboj M, Babady NE.
- J Mol Diagn. 2025 Oct 21;27(12):1224-1231. doi: 10.1016/j.jmoldx.2025.09.009.
- PMCID: PMC12831092
Jani K, et al.J Mol Diagn. 2025.PMCID: PMC12831092 -
Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.
- Heydt C, Ihle MA, Ilm K, Rehker J, Poon P, Siemanowski-Hrach J, Pappesch R, Wagener-Ryczek S, Jonas C, Fassunke J, Riedel R, Schultheis AM, Buettner R, Merkelbach-Bruse S, Siebolts U.
- J Mol Diagn. 2026 Jun 4;28(8):625-641. doi: 10.1016/j.jmoldx.2026.05.007.
- PMCID: PMC13494073
Heydt C, et al.J Mol Diagn. 2026.PMCID: PMC13494073 -
Validation of MyHPVscore: A High-Performance Human Papillomavirus Circulating Tumor DNA Laboratory-Developed Test.
- Currie J, Walline H, Hochfelder CG, Bhambhani C, Brummel CV, Sandford E, Bhangale A, Akhdar R, Buchakjian M, Casper KA, Chinn SB, Forner D, Malloy KM, Shah JL, Shuman AG, Stucken CL, Spector ME, Worden FP, Yalamanchi P, Heft Neal M, Swiecicki PL, Tewari M, Mierzwa ML, Prince ME, Brenner JC.
- J Mol Diagn. 2026 May 4;28(7):553-564. doi: 10.1016/j.jmoldx.2026.04.003.
- PMCID: PMC13494182
Currie J, et al.J Mol Diagn. 2026.PMCID: PMC13494182 -
Comprehensive Pathologic and Genetic Investigation of Four Young Adults with a Short QT Interval and Sudden Unexpected Death.
- Hata Y, Yamaguchi Y, Hirono K, Ichimata S, Mizumaki K, Nishida N.
- J Mol Diagn. 2026 May 4;28(7):565-574. doi: 10.1016/j.jmoldx.2026.04.004.
- PMCID: PMC13494085
Hata Y, et al.J Mol Diagn. 2026.PMCID: PMC13494085 -
Evaluation of Chimerism Testing by Next-Generation Sequencing Using Insertion/Deletion Markers: Analytical Validation and Examples of Clinical Utilization.
- Dutterer S, Moore C, Giddens M, Smith J, Williams J, Magwood J, Silva J, Murphey C, Bravo-Egana V.
- J Mol Diagn. 2026 Apr 22;28(7):535-552. doi: 10.1016/j.jmoldx.2026.04.002.
- PMCID: PMC13494106
Dutterer S, et al.J Mol Diagn. 2026.PMCID: PMC13494106 -
Solving the :: Fusion Nomenclature Challenge for File and Directory Naming.
- Bisson T, Kaluziak S, Zerbe N, Lennerz JK.
- J Mol Diagn. 2025 Sep 1;27(11):1070-3. doi: 10.1016/j.jmoldx.2025.08.002. Online ahead of print.
- PMCID: PMC13390193
Bisson T, et al.J Mol Diagn. 2025.PMCID: PMC13390193 -
Why Non-ASCII Unicode Characters Should Not Be Used in the Human Genome Variation Society Nomenclature.
- Dalgleish R, Freeman PJ, Wagstaff JF, Bruford EA, Fokkema IFAC.
- J Mol Diagn. Author manuscript. 2026 May;28(5):448-449. doi: 10.1016/j.jmoldx.2026.01.009.
- PMCID: PMC13197907
Dalgleish R, et al.J Mol Diagn. Author manuscript. 2026.PMCID: PMC13197907 -
Development of an End-to-End Total RNA Sequencing Quality Control Framework for Blood-Based Biomarker Discovery.
- Sesler CL, Shaginurova GI, Wylezinski LS, Grigorenko EV, Cockerill FR 3rd, Spurlock CF 3rd.
- J Mol Diagn. 2025 Jun 25;27(9):869-881. doi: 10.1016/j.jmoldx.2025.05.008.
- PMCID: PMC12489346
Sesler CL, et al.J Mol Diagn. 2025.PMCID: PMC12489346 -
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology.
- Carta MG, Tögel L, Hölsken A, Schubart C, Sticht H, Stöhr R, Spoerl S, Meidenbauer N, Hartmann A, Magni P, Haller F, Ferrazzi F.
- J Mol Diagn. 2026 Apr 3;28(6):469-484. doi: 10.1016/j.jmoldx.2026.03.004.
- PMCID: PMC13269341
Carta MG, et al.J Mol Diagn. 2026.PMCID: PMC13269341 -
Validation of a Low-Volume (100 μL) Plasma Protocol for HIV-1 RNA Quantification Using the Hologic Aptima HIV-1 Quant Dx Assay.
- Madurai LS, Reddy K, Nair S, Manivannan B, Pillay K, Mahomed S.
- J Mol Diagn. 2026 Apr 3;28(6):461-468. doi: 10.1016/j.jmoldx.2026.03.006.
- PMCID: PMC13269340
Madurai LS, et al.J Mol Diagn. 2026.PMCID: PMC13269340